Obesity and Mortality Rates

Handbook of Obesity: Epidemiology, Etiology, and Physiopathology: Volume 1, Third Edition

Volumn 1, Issue , 2014, Pages 503-513

  Whitlock, Gary ^a   Huxley, Rachel R ^b  

^a CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879371562     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b16473-50     Document Type: Chapter

References (99)

1. Ogden CL, Fryar CD, Carroll MD, et al. Mean Body Weight, Height, and Body Mass Index, United States 1960-2002. Hyattsville, MD: National Center for Health Statistics, 2004.
2. Health Survey for England-2009: Health and lifestyles. 2010. Available from: http://www.ic.nhs.uk/pubs/hse09report; accessed January 10, 2012.
3. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011;377:557-67.
4. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-96.
5. Emerging Risk Factors Collaboration. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: Collaborative analysis of 58 prospective studies. Lancet 2011;377:1085-95.
6. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Over-weight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
7. Reeves GK, Pirie K, Beral V, et al. Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study. BMJ 2007;335:1134.
8. World Health Organization Statistical Information System. WHO Mortality Database. 2010. Available from: http://www .who.int/whosis/mort/en; accessed November 15, 2011.
9. Mathers CD, Ma Fat D, Inoue M, et al. Counting the dead and what they died from: An assessment of the global status of cause of death data. B World Health Organ 2005;83:171-7.
10. Whitlock G, Huxley R. Count the dead, measure the living. Nat Rev Endocrinol 2011;7:317-8.
11. Setel PW, Macfarlane SB, Szreter S, et al. A scandal of invisibility: Making everyone count by counting everyone. Lancet 2007;370:1569-77.
12. Keys A, Fidanza F, Karvonen MJ, et al. Indices of relative weight and obesity. J Chron Dis 1972;25:329-43.
13. Gallagher D, Visser M, Sepúlveda D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996;143:228-39.
14. Zhao W, Zhai Y, Hu J, et al. Economic burden of obesity-related chronic diseases in mainland China. Obes Rev 2008; 9:62-7.
15. Frankenfield DC, Rowe WA, Cooney RN, et al. Limits of body mass index to detect obesity and predict body composition. Nutrition 2001;17:26-30.
16. Deurenberg P, Yap M, van Stavaren WA. Body mass index and percent body fat: A metaanalysis among different ethnic groups. Int J Obesity 1998;22:1164-71.
17. Micozzi MS, Harris TM. Age variations in the relation of body mass indices to estimates of body fat and muscle mass. Am J Phys Anthropol 1990;881:375-9.
18. Yusuf S, Hawken S, Ôunpuu S, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 coun-tries: A case-control study. Lancet 2005;366:1640-9.
19. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41.
20. Flegal KM, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012;307:491-7.
21. Shields M, Tremblay MS, Laviolette M, et al. Fitness of Canadian adults: Results from the 2007-2009 Canadian Health Measures Survey. Health Rep/Stat Canada 2010;21:1-15.
22. Castetbon K, Vernay M, Malon A, et al. Dietary intake, physical activity and nutritional status in adults: The French nutrition and health survey (ENNS, 2006-2007). Br J Nutr 2009;102:733-43.
23. Ministry of Health Labour and Welfare (Japan). The National Health and Nutrition Survey in Japan, 2007 [in Japanese, chapters 3 and 6]. Tokyo; 2009. Available from: http://www .mhlw.go.jp/bunya/kenkou/eiyou09/01.html; accessed March 21, 2012.
24. United Nations Department of Economic and Social Affairs (Population Division). World Population Prospects: The 2010 Revision; 2011. Available from: http://esa.un.org/unpd/wpp/Excel-Data/population.htm; accessed July 12, 2011.
25. Zaridze D, Brennan P, Boreham J, et al. Alcohol and cause-specific mortality in Russia: A retrospective case-control study of 48 557 adult deaths. Lancet 2009;373:2201-14.
26. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88:15-9.
27. Abdullah A, Wolfe R, Stoelwinder JU, et al. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol 2011;40:985-96.
28. Franks PW, Hanson RL, Knowler WC, et al. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010;362:485-93.
29. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA 1999;282:1523-9.
30. Romero-Corral A, Montori VM, Somers VK, et al. Association of body weight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies. Lancet 2006;368:666-78.
31. Kalantar-Zadeh K, Kovesdy CP, Derose SF, et al. Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol 2007;3:493-506.
32. Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55-61.
33. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
34. Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxes of recurrence risk research. JAMA 2011;305:822-3.
35. Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990;322:882-9.
36. Ni Mhurchu C, Rodgers A, Pan WH, et al. Body mass index and cardiovascular disease in the Asia-Pacific region: An overview of 33 cohorts involving 310 000 participants. Int J Epidemiol 2004;33:751-8.
37. Jee SH, Pastor-Barriuso R, Appel LJ, et al. Body mass index and incident ischemic heart disease in South Korean men and women. Am J Epidemiol 2005;162:42-8.
38. Chen Z, Yang G, Zhou M, et al. Body mass index and mortality from ischaemic heart disease in a lean population: 10 year prospective study of 220 000 adult men. Int J Epidemiol 2006;35:141-50.
39. Chen Z, Yang G, Offer A, et al. Body mass index and mortality in China: A 15-year prospective study of 220 000 men. Int J Epidemiol 2012;(Epub ahead of print).
40. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 1998;6(Suppl 2): 51S-209S.
41. Cholesterol Treatment Trialists’ Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010;376:1670-81.
42. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomised trials. Lancet 2003;362: 1527-35.
43. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
44. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007;370:1829-39.
45. Woodward M, Zhang X, Barzi F, et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 2003;26:360-6.
46. Rajala MW, Scherer PE. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and athero-sclerosis. Endocrinology 2003;144:3765-73.
47. Timpson NJ, Harbord R, Davey Smith G, et al. Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO/MC4R genotype. Hypertension 2009;54:84-90.
48. Whitlock G. Mortality trends. 2010; Available from: http://www.mortality-trends.org, accessed March 21, 2012.
49. Wijeysundera HC, Machado M, Farahati F, et al. Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA 2010;303:1841-7.
50. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98.
51. Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005;294:1773-81.
52. Farzadfar F, Finucane MM, Danaei G, et al. National, regional, and global trends in serum total cholesterol since 1980: Systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 2011;377:578-86.
53. Danaei G, Finucane MM, Lin JK, et al. National, regional, and global trends in systolic blood pressure since 1980: Systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011;377:568-77.
54. Syamlal G, Mazurek JM, Malarcher AM. Current cigarette smoking prevalence among working adults-United States, 2004-2010. Morb Mortal Wkly Rep 2011;60:1305-9.
55. Pierce JP. International comparisons of trends in cigarette smoking prevalence. Am J Public Health 1989;79:152-7.
56. Baigent C, Collins R, Appleby P, et al. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 1998;316:1337-43.
57. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316 099 white men. Arch Intern Med 1992;152:56-64.
58. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 2004;328:1519-28.
59. Capewell S, Ford ES. Why have total cholesterol levels declined in most developed countries? BMC Public Health 2011;11; doi:10.1186/1471-2458-11-641.
60. Capewell S, Buchan S. Why have sustained increases in obesity and type 2 diabetes not offset declines in cardiovascular mortality over recent decades in Western countries? Nutr Metab Cardiovasc Dis 2012;(Epub ahead of print).
61. Lawlor D, Smith G, Leon D, et al. Secular trends in mortality by stroke subtype in the 20th century: A retrospective analysis. Lancet 2002;360:1818-23.
62. Song YM, Sung J, Davey Smith G, et al. Body mass index and ischemic and hemorrhagic stroke: A prospective study in Korean men. Stroke 2004;35:831-6.
63. Park JW, Lee SY, Kim SY, et al. BMI and stroke risk in Korean women. Obesity 2008;16:396-401.
64. Rexrode KM, Hennekens CH, Willett WC, et al. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA 1997;277:1539-45.
65. Jood K, Jern C, Wilhelmsen L, et al. Body mass index in mid-life is associated with a first stroke in men: A prospective population study over 28 years. Stroke 2004;35:2764-9.
66. Zhou M, Offer A, Yang G, et al. Body mass index, blood pressure, and mortality from stroke: A nationally representative prospective study of 212,000 Chinese men. Stroke 2008;39:753-9.
67. Huxley RR, Lopez FL, Folsom AR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and bor-derline risk factors: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 2011;123:1501-8.
68. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002;347:305-13.
69. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78.
70. IARC Handbooks of Cancer Prevention: Volume 6, Weight Control and Physical Activity. Lyon: IARC Press, 2002. Volume downloadable at http://www.iarc.fr/en/publications/pdfs-online/prev/handbook6/Handbook6-0.pdf.
71. Calle EE, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91.
72. Berrington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatic cancer. Brit J Cancer 2003;89:519-23.
73. Pan SY, Johnson KC, Ugnat AM, et al. Association of obesity and cancer risk in Canada. Am J Epidemiol 2004;159:259-68.
74. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: A meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007;16:2533-47.
75. Bray GA. Health hazards of obesity. Obesity 1996;25:907-19.
76. Magnusson PKE, Rasmussen F, Lawlor DA, et al. Association of body mass index with suicide mortality: A prospective cohort study of more than one million men. Am J Epidemiol 2006;163:1-8.
77. Mukamal KJ, Kawachi I, Miller M, et al. Body mass index and risk of suicide among men. Arch Intern Med 2007;167:468-75.
78. Whitlock G. Is body mass index a risk factor for motor vehicle driver injury? A cohort study with prospective and retrospective outcomes. Int J Epidemiol 2003;32:147-9.
79. Gaemers IC, Groen AK. New insights in the pathogenesis of non-alcoholic fatty liver disease. Curr Opin Lipidol 2006;17:268-73.
80. Adiels M, Taskinen MR, Packard C, et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006;49:755-65.
81. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006;43:S99-112.
82. Liu B, Balkwill A, Reeves G, et al. Body mass index and risk of liver cirrhosis in middle aged UK women: Prospective study. BMJ 2010;340; doi:10.1136/bmj.c912.
83. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: An analysis of routine data. Lancet 2006;367:52-6.
84. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107:450-5.
85. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: A metabolic pathway to chronic liver disease. Hepatology 2005;42:987-1000.
86. Kelley DE, McKolanis TM, Hegazi RAF, et al. Fatty liver in type 2 diabetes mellitus: Relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 2003;285:E906-16.
87. Goldacre MJ, Duncan ME, Cook-Mozaffari P, et al. Trends in mortality rates for death-certificate-coded diabetes mellitus in an English population 1979-99. Diabetic Med 2004;21:936-9.
88. Wang Y, Chen X, Song Y, et al. Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int 2008;73:19-33.
89. Carey VJ, Walters EE, Colditz GA, et al. Body fat distribution and risk of non-insulin-dependent diabetes mellitus. Am J Epidemiol 1997;145:614-9.
90. Folsom AR, Kushi LH, Anderson KE, et al. Associations of general and abdominal obesity with multiple health outcomes in older women: The Iowa Women’s Health Study. Arch Intern Med 2000;160:2117-28.
91. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010;363:2211-9.
92. Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-20.
93. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763-78.
94. Gu D, He J, Duan X, et al. Body weight and mortality among men and women in China. JAMA 2006;295:776-83.
95. Jee SH, Sull JW, Park J, et al. Body-mass index and mortality in Korean men and women. N Engl J Med 2006;355:779-87.
96. Flegal KM, Graubard BI, Williamson DF, et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861-7.
97. Flegal KM, Graubard BI, Williamson DF, et al. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007;298:2028-37.
98. Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 2011;364:719-29.
99. Pednekar MS, Hakama M, Herbert JR, et al. Association of body mass index with all-cause and cause-specific mortality: Findings from a prospective cohort study in Mumbai (Bombay), India. Int J Epidemiol 2008;37:524-35.